Effects of weight loss on asthma control in obese patients with severe asthma

European Respiratory Journal

Volumn 43, Issue 5, 2014, Pages 1368-1377

  Dias Júnior, Sérvulo Azevedo ^a   Reis, Monica ^a   De Carvalho Pinto, Regina Maria ^a   Stelmach, Rafael ^a   Halpern, Alfredo ^a   Cukier, Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EOTAXIN; IMMUNOGLOBULIN E; LEPTIN; NITRIC OXIDE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRANSFORMING GROWTH FACTOR BETA1; CORTICOSTEROID; CYTOKINE;

ADULT; ALLERGIC ASTHMA; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA CONTROL TEST; BODY MASS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHILIA; FEMALE; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX DISEASE HEALTH RELATED QUALITY OF LIFE SCALE; HEALTH PROGRAM; HORMONE BLOOD LEVEL; HUMAN; LOW CALORY DIET; MALE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; WEIGHT REDUCTION; BODY WEIGHT; COMPLICATION; INFLAMMATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT OUTCOME; VITAL CAPACITY;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BODY WEIGHT; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; VITAL CAPACITY; WEIGHT LOSS;

EID: 84899873284     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00053413     Document Type: Article

References (32)

1. Serra-Batlles J, Plaza V, Morejon E, et al. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322-1326.
2. Sullivan SD, Rasouliyan L, Russo PA, et al. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy 2007; 62: 126-133.
3. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004; 92: 32-39.
4. Carvalho-Pinto RM, Cukier A, Angelini L, et al. Clinical characteristics and possible phenotypes of an adult severe asthma population. Respir Med 2012; 106: 47-56.
5. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175: 661-666.
6. Taylor B, Mannino D, Brown C, et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63: 14-20.
7. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101: 2240-2247.
8. Sutherland ER, Goleva E, Strand M, et al. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178: 682-687.
9. Mosen DM, Schatz M, Magid DJ, et al. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122: 507-511.
10. Farah CS, Kermode JA, Downie SR, et al. Obesity is a determinant of asthma control independent of inflammation and lung mechanics. Chest 2011; 140: 659-666.
11. Eneli IU, Skybo T, Camargo CA. Weight loss and asthma: a systematic review. Thorax 2008; 63: 671-676.
12. Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol 2011; 128: 508-515.
13. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
14. Halpern A, Pepe R, Monegaglia AP, et al. Efficacy and tolerability of the association of sibutramine and orlistat for six months in overweight and obese patients. J Obes 2010; 2010: 602537.
15. Angelini L, Robles-Ribeiro PG, Carvalho-Pinto RM, et al. Two-year evaluation of an educational program for adult outpatients with asthma. J Bras Pneumol 2009; 35: 618-627.
16. Leite M, Ponte EV, Petroni J, et al. Avaliação do questionário de controle da asma validado para uso no Brasil [Evaluation of the asthma control questionnaire validated for use in Brazil]. J Bras Pneumol 2008; 34: 756-763.
17. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
18. Sousa TC, Jardim JJ, Jones P. Validation of the Saint George's Respiratory Questionnaire in patients with chronic obstructive pulmonary disease in Brazil. J Bras Pneumol 2000; 26: 119-125.
19. Fornari F, Gruber AC, Lopes AB, et al. Questionário de sintomas na doença do refluxo gastroesofágico [Symptom's questionnaire for gastroesophageal reflux disease]. Arq Gastroenterol 2004; 41: 263-267.
20. Saraiva-Romanholo BM, Barnabé V, Carvalho ALI, et al. Comparison of three methods for differential cell count in induced sputum. Chest 2003; 124: 1060-1066.
21. Lessard A, Turcotte H, Cormier Y, et al. Obesity and asthma: a specific phenotype? Chest 2008; 134: 317-23.
22. van Veen IH, ten Brinke A, Sterk PJ, et al. Airway inflammation in obese and nonobese patients with difficult-totreat asthma. Allergy 2008; 63: 570-574.
23. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
24. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181: 315-323.
25. Todd DC, Armstrong S, D'Silva L, et al. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts. Clin Exp Allergy 2007; 37: 1049-1054.
26. Stenius-Aarniala B, Poussa T, Kvarnström J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320: 827-832.
27. Bafadhel M, Singapuri A, Terry S, et al. Body mass and fat mass in refractory asthma: an observational 1 year follow-up study. J Allergy (Cairo) 2010; 2010: 251758.
28. Haselkorn T, Fish J, Chipps BE, et al. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. Respir Med 2009; 103: 274-283.
29. Scott HA, Gibson PG, Garg ML, et al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy 2013; 43: 36-49.
30. Amelink M, de Groot JC, de Nijs SB, et al. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol 2013; 132: 336-341.
31. Amelink M, de Nijs SB, de Groot JC, et al. Three phenotypes of adult-onset asthma. Allergy 2013; 68: 674-680.
32. Mendes FAR, Almeida FM, Cukier A, et al. Effects of aerobic training on airway inflammation in asthmatic patients. Med Sci Sports Exercise 2011; 43: 197-203.